Medical Economics February 1, 2024
Richard Payerchin

Administration, HHS tout milestone day on road to lowering drug prices for beneficiaries.

The United States is making an offer to Big Pharma on the 10 most commonly used drugs for Medicare.

Whether it’s an offer they can’t refuse remains to be seen.

On Feb. 1, the U.S. Centers for Medicare & Medicaid Services (CMS) will send initial offers to drug manufacturers on the first 10 drugs selected for negotiations to bring down prescription prices. “This is the first time ever that Medicare is not accepting the drug prices the pharmaceutical companies set,” said a statement from the White House.

In statements, President Joe Biden and the U.S. Department of Health and Human Services (HHS) touted Feb. 1, 2024, as...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, CMS, Govt Agencies, HHS, Insurance, Medicare, Pharma, Pharma / Biotech
Medicare Coverage Of Medical Technologies In A New Era
An Argument For A New Medicare Prospective Payment System Methodology For Certified Community Behavioral Health Clinics
What's going on with physician pay?
Ep. 54: Medicare cuts and physician challenges with Norman K. "Kip" Beals III, MD
Home Improvements Can Help People Age Independently. But Medicare Seldom Picks Up the Bill.

Share This Article